Table 1B.

Regulation of surface molecules by DSP30 and CD40 ligation in normal B cells

DSP30CD40LF-cells P Value (1)CD40LF-cells/DSP30 P Value (2)
Mean MFIR Induction SEM +/− Mean MFIR InductionSEM +/− Mean MFIR Induction SEM +/−
CD40 2.3  0.2  1.4  0.2  .13  1.9  0.2  .38 
CD80  2.3  0.4  3.0  0.3  .39  3.9  0.4 .06  
CD86  4.6  0.7  6.7  1.7  .41  10.7 3.0  .09  
MHC class I  1.7  0.2  1.5  0.3  .59 2.3  0.8  .94  
CD58  3.3  0.5  4.5  0.8 .75  6.3  0.8  .06  
CD54  2.0  0.2  13.3 2.3  .03  12.6  3.2  .31  
CD95  0.9  0.1 6.4  1.2  .03  1.4  0.2  .03 
DSP30CD40LF-cells P Value (1)CD40LF-cells/DSP30 P Value (2)
Mean MFIR Induction SEM +/− Mean MFIR InductionSEM +/− Mean MFIR Induction SEM +/−
CD40 2.3  0.2  1.4  0.2  .13  1.9  0.2  .38 
CD80  2.3  0.4  3.0  0.3  .39  3.9  0.4 .06  
CD86  4.6  0.7  6.7  1.7  .41  10.7 3.0  .09  
MHC class I  1.7  0.2  1.5  0.3  .59 2.3  0.8  .94  
CD58  3.3  0.5  4.5  0.8 .75  6.3  0.8  .06  
CD54  2.0  0.2  13.3 2.3  .03  12.6  3.2  .31  
CD95  0.9  0.1 6.4  1.2  .03  1.4  0.2  .03 

Cells were cultured for 48 hours. MFIR and MFIR-induction were calculated as described in “Material and Methods” section. MFIR induction is presented as mean ± SEM of 11 samples from B-CLL patients (Table 1A) and 7 normal control subjects (Table 1B). The Wilcoxon signed rank test was used to determine statistically significant differences, comparing the MFIR induced by DSP30 stimulation versus CD40-ligation (P value (1)). A secondP value (P value (2)) was determined by testing for a difference between the combination of both stimuli and the maximum MFIR-induction of either stimulus alone. The Bonferroni-Holm correction was used to adjust significance levels. Statistical significantP values are indicated by asterisks. CLL = chronic lymphocytic leukemia; MFIR = mean fluorescence intensity ratio.

Close Modal

or Create an Account

Close Modal
Close Modal